Company registration number 14684001 (England and Wales)
MORRAB PHARMA LTD
ANNUAL REPORT AND UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 28 FEBRUARY 2024
PAGES FOR FILING WITH REGISTRAR
MORRAB PHARMA LTD
CONTENTS
Page
Directors' report
1
Balance sheet
2
Notes to the financial statements
3
MORRAB PHARMA LTD
DIRECTORS' REPORT
FOR THE YEAR ENDED 28 FEBRUARY 2024
- 1 -

The directors present their annual report and financial statements for the year ended 28 February 2024.

Principal activities

The principal activity of the company continued to be that of to be dormant.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr C A Amadi
Mr A I Mohammed
Small companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the small companies exemption.

On behalf of the board
Mr A I Mohammed
Director
12 November 2024
MORRAB PHARMA LTD
BALANCE SHEET
AS AT
28 FEBRUARY 2024
28 February 2024
- 2 -
2024
Notes
£
£
Current assets
Debtors
10,000
Net current assets
10,000
Capital and reserves
-
Called up share capital
10,000

In accordance with section 444 of the Companies Act 2006, all of the members of the company have consented to the preparation of abridged financial statements pursuant to paragraph 1A of Schedule 1 to the Small Companies and Groups (Accounts and Directors’ Report) Regulations (SI 2008/409)(b).

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 28 February 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 12 November 2024 and are signed on its behalf by:
Mr A I Mohammed
Director
Company registration number 14684001 (England and Wales)
MORRAB PHARMA LTD
BALANCE SHEET (CONTINUED)
AS AT
28 FEBRUARY 2024
28 February 2024
- 3 -
1
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
Number
Total
2
2024-02-282023-02-23true12 November 2024CCH SoftwareCCH Accounts Production 2024.100No description of principal activityMr C A AmadiMr A I Mohammedfalsefalse146840012023-02-232024-02-2814684001bus:Director12023-02-232024-02-2814684001bus:Director22023-02-232024-02-28146840012024-02-2814684001core:ShareCapital2024-02-2814684001bus:EntityHasNeverTraded2023-02-232024-02-2814684001bus:PrivateLimitedCompanyLtd2023-02-232024-02-2814684001bus:SmallCompaniesRegimeForAccounts2023-02-232024-02-2814684001bus:FRS1022023-02-232024-02-2814684001bus:AuditExemptWithAccountantsReport2023-02-232024-02-2814684001bus:FullAccounts2023-02-232024-02-28xbrli:purexbrli:sharesiso4217:GBP